The gut microbiota as a therapeutic target in IBD and metabolic disease: a role for the bile acid receptors FXR and TGR5

An obesity-associated gut microbiome with increased capacity for energy harvest

Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · see citing works

A human gut microbial gene catalogue established by metagenomic sequencing

MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · see citing works

Human gut microbes associated with obesity

Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · see citing works

A core gut microbiome in obese and lean twins

Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · see citing works

Changes of Intestinal Functions in Liver Cirrhosis

Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820 · see citing works

The gut microbiota shapes intestinal immune responses during health and disease

Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029 · see citing works

Richness of human gut microbiome correlates with metabolic markers

Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662 · see citing works

Functional interactions between the gut microbiota and host metabolism

Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387 · see citing works

Interactions Between the Microbiota and the Immune System

Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · see citing works

Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice

Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · see citing works

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk

Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,402 · see citing works

Gut metagenome in European women with normal, impaired and diabetic glucose control

Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115 · see citing works

Bile salt biotransformations by human intestinal bacteria

Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829 · see citing works

Fetal nutrition and cardiovascular disease in adult life

Barker, D. J. P., Godfrey, K. M., Gluckman, P. D., Harding, J. E., Owens, J. A., & Robinson, J. S. (1993) · The Lancet · doi:10.1016/0140-6736(93)91224-a · Cited by 2,753 · see citing works

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r79 · Cited by 2,713 · see citing works

Succession of microbial consortia in the developing infant gut microbiome

Koenig, J. E., Spor, A., Scalfone, N., Fricker, A. D., Stombaugh, J., Knight, R., Angenent, L. T., & Ley, R. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000081107 · Cited by 2,540 · see citing works

Microbiota and SCFA in lean and overweight healthy subjects

Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457 · see citing works

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist

Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331 · see citing works

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220 · see citing works

Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine

Hooper, L. V., Wong, M. H., Thelin, A., Hansson, L., Falk, P. G., & Gordon, J. I. (2001) · Science · doi:10.1126/science.291.5505.881 · Cited by 2,202 · see citing works

TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis

Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885 · see citing works

Dietary intervention impact on gut microbial gene richness

Cotillard, A., Kennedy, S. P., Kong, L. C., Prifti, E., Pons, N., Le Chatelier, E., Almeida, M., Quinquis, B., Levenez, F., Galleron, N., et al. (2013) · Nature · doi:10.1038/nature12480 · Cited by 1,832 · see citing works

The interaction between bacteria and bile

Begley, M., Gahan, C. G. M., & Hill, C. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.09.003 · Cited by 1,793 · see citing works

Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation

Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., & Staels, B. (2009) · Physiological Reviews · doi:10.1152/physrev.00010.2008 · Cited by 1,678 · see citing works

Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR

Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636 · see citing works

A G Protein-coupled Receptor Responsive to Bile Acids

Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628 · see citing works

Bile acids: regulation of synthesis

Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,567 · see citing works

Symptomatic atherosclerosis is associated with an altered gut metagenome

Karlsson, F. H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., Bäckhed, F., & Nielsen, J. (2012) · Nature Communications · doi:10.1038/ncomms2266 · Cited by 1,371 · cited 3× · see citing works

Low counts of Faecalibacterium prausnitzii in colitis microbiota

Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275 · see citing works

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ

Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,251 · see citing works

Human colonic microbiota associated with diet, obesity and weight loss

Duncan, S. H., Lobley, G. E., Holtrop, G., Ince, J., Johnstone, A. M., Louis, P., & Flint, H. J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.155 · Cited by 1,222 · see citing works

Identification of a nuclear receptor that is activated by farnesol metabolites

Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90530-8 · Cited by 1,210 · see citing works

Pleiotropic Roles of Bile Acids in Metabolism

de Aguiar Vallim, T. Q., Tarling, E. J., & Edwards, P. A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.013 · Cited by 1,209 · see citing works

Gut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects

Radilla-Vázquez, R. B., Parra‐Rojas, I., Martínez-Hernández, N. E., Márquez‐Sandoval, F., Illades‐Aguiar, B., & Castro-Alarcón, N. (2016) · Obesity Facts · doi:10.1159/000442479 · Cited by 1,200 · see citing works

Bile Salt Hydrolase Activity in Probiotics

Begley, M., Hill, C., & Gahan, C. G. M. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.3.1729-1738.2006 · Cited by 1,187 · see citing works

Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor

Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164 · see citing works

Disordered lipid metabolism and the pathogenesis of insulin resistance.

Savage, D. B., Petersen, K. F., & Shulman, G. I. (2007) · Physiological Reviews · doi:10.1152/physrev.00024.2006 · Cited by 1,107 · see citing works

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome

Jones, B. V., Begley, M., Hill, C., Gahan, C. G. M., & Marchesi, J. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804437105 · Cited by 1,098 · see citing works

Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition

Vickers, M. H., Breier, B. H., Cutfield, W. S., Hofman, P. L., & Gluckman, P. D. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.1.e83 · Cited by 999 · see citing works

Identification of membrane-type receptor for bile acids (M-BAR)

Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993 · see citing works

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 961 · see citing works

Commensal bacteria at the interface of host metabolism and the immune system

Brestoff, J. R., & Artis, D. (2013) · Nature Immunology · doi:10.1038/ni.2640 · Cited by 945 · see citing works

FXR is a molecular target for the effects of vertical sleeve gastrectomy

Ryan, K. K., Tremaroli, V., Clemmensen, C., Kovatcheva-Datchary, P., Myronovych, A., Karns, R., Wilson-Pérez, H. E., Sandoval, D. A., Kohli, R., Bäckhed, F., et al. (2014) · Nature · doi:10.1038/nature13135 · Cited by 931 · see citing works

Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases

Duboc, H., Rajca, S., Rainteau, D., Benarous, D., Maubert, M.-A., Quervain, E., Thomas, G., Barbu, V., Humbert, L., Despras, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302578 · Cited by 930 · see citing works

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

Gadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut · doi:10.1136/gut.2010.212159 · Cited by 870 · cited 6× · see citing works

Meta‐analyses of human gut microbes associated with obesity and IBD

Walters, W. A., Xu, Z., & Knight, R. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.09.039 · Cited by 836 · see citing works

Defining a Healthy Human Gut Microbiome: Current Concepts, Future Directions, and Clinical Applications

Bäckhed, F., Fraser, C. M., Ringel, Y., Sanders, M. E., Sartor, R. B., Sherman, P. M., Versalovic, J., Young, V., & Finlay, B. B. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.10.012 · Cited by 836 · see citing works

Toward defining the autoimmune microbiome for type 1 diabetes

Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Novelo, L. L., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyöty, H., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2010.92 · Cited by 806 · see citing works

Bile acid receptors as targets for drug development

Schaap, F. G., Trauner, M., & Jansen, P. L. M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.151 · Cited by 696 · see citing works

High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota

Zoetendal, E. G., Rajilić-Stojanović, M. D., & de Vos, W. M. (2008) · Gut · doi:10.1136/gut.2007.133603 · Cited by 672 · see citing works

The bile acid receptor FXR is a modulator of intestinal innate immunity

Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803978 · Cited by 655 · see citing works

Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response

Wang, Y.-D., Chen, W.-D., Wang, M., Yu, D., Forman, B. M., & Huang, W. (2008) · Hepatology · doi:10.1002/hep.22519 · Cited by 639 · see citing works

TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading

Pols, T. W. H., Nomura, M., Harach, T., Sasso, G. L., Oosterveer, M. H., Thomas, C., Rizzo, G., Gioiello, A., Adorini, L., Pellicciari, R., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.006 · Cited by 622 · see citing works

Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut

Joyce, S. A., MacSharry, J., Casey, P. G., Kinsella, M., Murphy, E. F., Shanahan, F., Hill, C., & Gahan, C. G. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323599111 · Cited by 604 · see citing works

Gut Microbiota and Its Possible Relationship With Obesity

DiBaise, J. K., Zhang, H., Crowell, M. D., Krajmalnik‐Brown, R., Decker, G. A., & Rittmann, B. E. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.4.460 · Cited by 598 · see citing works

Intestinal Bacteria and the Regulation of Immune Cell Homeostasis

Hill, D. A., & Artis, D. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101330 · Cited by 586 · see citing works

Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity

Vrieze, A., Out, C., Fuentes, S., Jonker, L., Reuling, I. J., Kootte, R. S., van Nood, E., Holleman, F., Knaapen, M., Romijn, J. A., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.034 · Cited by 583 · see citing works

Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine Published, JLR Papers in Press, August 24, 2007.

Kim, I., Ahn, S.-H., Inagaki, T., Choi, M., Ito, S., Guo, G. L., Kliewer, S., & Gonzalez, F. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700330-jlr200 · Cited by 575 · see citing works

The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice

Cariou, B., van Harmelen, K., Durán-Sandoval, D., van Dijk, T. H., Grefhorst, A., Abdelkarim, M., Caron, S., Torpier, G., Fruchart, J., Gonzalez, F. J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510258200 · Cited by 546 · see citing works

A Guide to Enterotypes across the Human Body: Meta-Analysis of Microbial Community Structures in Human Microbiome Datasets

Koren, O., Knights, D., Gonzalez, A., Waldron, L., Segata, N., Knight, R., Huttenhower, C., & Ley, R. E. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002863 · Cited by 508 · see citing works

The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) in mice

Wang, Y., Chen, W., Yu, D. D., FORMAN, B. M., & Huang, W. (2011) · Hepatology · doi:10.1002/hep.24525 · Cited by 488 · see citing works

The function of our microbiota: who is out there and what do they do?

Ottman, N., Smidt, H., de Vos, W. M., & Belzer, C. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00104 · Cited by 485 · see citing works

The bile acid TGR5 membrane receptor: from basic research to clinical application

Duboc, H., Taché, Y., & Hofmann, A. F. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.10.021 · Cited by 473 · see citing works

Combinatorial roles of nuclear receptors in inflammation and immunity

Glass, C. K., & Ogawa, S. (2005) · Nature reviews. Immunology · doi:10.1038/nri1748 · Cited by 463 · see citing works

Beyond intestinal soap—bile acids in metabolic control

Kuipers, F., Bloks, V. W., & Groen, A. K. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.60 · Cited by 453 · see citing works

Differences in gut microbiota composition between obese and lean children: a cross-sectional study

Bervoets, L., Hoorenbeeck, K. V., Kortleven, I., Noten, C. V., Hens, N., Vael, C., Goossens, H., Desager, K., & Vankerckhoven, V. (2013) · Gut Pathogens · doi:10.1186/1757-4749-5-10 · Cited by 452 · see citing works

Specificities of the fecal microbiota in inflammatory bowel disease

Sokol, H., Seksik, P., Rigottier‐Gois, L., Lay, C., Lepage, P., Podglajen, I., Marteau, P. R., & Dore, J. M. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000200323.38139.c6 · Cited by 447 · see citing works

Bacterial translocation from the gastrointestinal tract

Berg, R. D. (1995) · Trends in Microbiology · doi:10.1016/s0966-842x(00)88906-4 · Cited by 443 · see citing works

The Role of Probiotic Lactic Acid Bacteria and Bifidobacteria in the Prevention and Treatment of Inflammatory Bowel Disease and Other Related Diseases: A Systematic Review of Randomized Human Clinical Trials

Sáez‐Lara, M. J., Gómez‐Llorente, C., Plaza‐Díaz, J., & Gil, Á. (2015) · BioMed Research International · doi:10.1155/2015/505878 · Cited by 390 · see citing works

FXR: a metabolic regulator and cell protector

Wang, Y.-D., Chen, W.-D., Moore, D. D., & Huang, W. (2008) · Cell Research · doi:10.1038/cr.2008.289 · Cited by 389 · see citing works

FXR signaling in the enterohepatic system

Matsubara, T., Li, F., & Gonzalez, F. J. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.05.004 · Cited by 383 · see citing works

The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis

Cipriani, S., Mencarelli, A., Chini, M. G., Distrutti, E., Renga, B., Bifulco, G., Baldelli, F., Donini, A., & Fiorucci, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025637 · Cited by 382 · see citing works

A metagenomic insight into our gut's microbiome

Lepage, P., Leclerc, M., Joossens, M., Mondot, S., Blottière, H. M., Raes, J., Ehrlich, S. D., & Dore, J. M. (2012) · Gut · doi:10.1136/gutjnl-2011-301805 · Cited by 371 · see citing works

Microbiota conservation and BMI signatures in adult monozygotic twins

Tims, S., Derom, C., Jonkers, D. M., Vlietinck, R., Saris, W. H., Kleerebezem, M., de Vos, W. M., & Zoetendal, E. G. (2013) · The ISME Journal · doi:10.1038/ismej.2012.146 · Cited by 367 · see citing works

Microbiota Modification with Probiotics Induces Hepatic Bile Acid Synthesis via Downregulation of the Fxr-Fgf15 Axis in Mice

Degirolamo, C., Rainaldi, S., Bovenga, F., Murzilli, S., & Moschetta, A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.032 · Cited by 356 · see citing works

THE FUNCTION OF BILE SALTS IN FAT ABSORPTION. THE SOLVENT PROPERTIES OF DILUTE MICELLAR SOLUTIONS OF CONJUGATED BILE SALTS

Hofmann, A. (1963) · Biochemical Journal · doi:10.1042/bj0890057 · Cited by 353 · see citing works

Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity

Prawitt, J., Abdelkarim, M., Stroeve, J. H. M., Popescu, I. R., Duez, H., Velagapudi, V., Dumont, J., Bouchaert, E., van Dijk, T. H., Lucas, A., et al. (2011) · Diabetes · doi:10.2337/db11-0030 · Cited by 327 · see citing works

The enterohepatic circulation of bile acids in mammals: form and functions

Alan, F. (2009) · Frontiers in bioscience · doi:10.2741/3399 · Cited by 321 · see citing works

Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats

Lorenzo-Zúñiga, V., Bartolí, R., Planas, R., Hofmann, A. F., Viñado, B., Hagey, L. R., Hernández, J. M., Mañé, J., Alvarez, M. A., Ausina, V., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50116 · Cited by 321 · see citing works

Nuclear receptors: Decoding metabolic disease

Sonoda, J., Pei, L., & Evans, R. M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.016 · Cited by 313 · see citing works

Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease

Dupont, A. W., Richards, Jelinek, K. A., Krill, J. T., Rahimi, E. F., & Ghouri, Y. A. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s27530 · Cited by 303 · see citing works

Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood

Penders, J., Gerhold, K., Stobberingh, E. E., Thijs, C. T., Zimmermann, K., Lau, S., & Hamelmann, E. H. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.043 · Cited by 299 · see citing works

Effects of Surgical and Dietary Weight Loss Therapy for Obesity on Gut Microbiota Composition and Nutrient Absorption

Damms-Machado, A., Mitra, S., Schollenberger, A. E., Kramer, K. M., Meile, T., Königsrainer, A., Huson, D. H., & Bischoff, S. C. (2015) · BioMed Research International · doi:10.1155/2015/806248 · Cited by 291 · see citing works

Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice

Maruyama, T., Tanaka, K., Suzuki, J., Miyoshi, H., Harada, N., Nakamura, T., Miyamoto, Y., Kanatani, A., & Tamai, Y. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06546 · Cited by 285 · see citing works

Screening of Lactic Acid Bacteria for Bile Salt Hydrolase Activity

Tanaka, H., Doesburg, K. K., Iwasaki, T., & Mierau, I. (1999) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(99)75506-2 · Cited by 283 · see citing works

Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial

Jones, M. L., Martoni, C. J., & Prakash, S. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.126 · Cited by 277 · see citing works

The Developmental Origins, Mechanisms, and Implications of Metabolic Syndrome1–3

Bruce, K. D., & Hanson, M. A. (2010) · Journal of Nutrition · doi:10.3945/jn.109.111179 · Cited by 269 · see citing works

The G Protein-Coupled Bile Acid Receptor, TGR5, Stimulates Gallbladder Filling

Li, T., Holmstrom, S. R., Kır, S., Umetani, M., Schmidt, D. R., Kliewer, S. A., & Mangelsdorf, D. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0460 · Cited by 267 · see citing works

Increase in fecal primary bile acids and dysbiosis in patients with diarrhea‐predominant irritable bowel syndrome

Duboc, H., Rainteau, D., Rajca, S., Humbert, L., Farabos, D., Maubert, M., Grondin, V., Jouet, P., Bouhassira, D., Seksik, P., et al. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01893.x · Cited by 256 · see citing works

Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure

渡辺, 光., Horai, Y., Houten, S. M., Morimoto, K., Sugizaki, T., Arita, E., Mataki, C., Sato, H., Tanigawara, Y., Schoonjans, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248203 · Cited by 255 · see citing works

How bile acids confer gut mucosal protection against bacteria

Hofmann, A. F., & Eckmann, L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600780103 · Cited by 239 · see citing works

Life at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and disease

Zeißig, S., & Blumberg, R. S. (2014) · Nature Immunology · doi:10.1038/ni.2847 · Cited by 237 · see citing works

Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events : a systematic review

McFarland, L. V. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005047 · Cited by 235 · see citing works

TGR 5 signalling inhibits the production of pro‐inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease

Yoneno∥, K., Hisamatsu, T., Shimamura, K., Kamada, N., Ichikawa, R., Kitazume, M. T., Mori, M., Uo, M., Namikawa, Y., Matsuoka, K., et al. (2013) · Immunology · doi:10.1111/imm.12045 · Cited by 229 · see citing works

The organic solute transporter α-β, Ostα-Ostβ, is essential for intestinal bile acid transport and homeostasis

Rao, A., Haywood, J., Craddock, A. L., Belinsky, M. G., Kruh, G. D., & Dawson, P. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712328105 · Cited by 226 · see citing works

Farnesoid X Receptor Deficiency in Mice Leads to Increased Intestinal Epithelial Cell Proliferation and Tumor Development

Maran, R. R. M., Thomas, A., Roth, M. E., Sheng, Z., Esterly, N., Pinson, D. M., Gao, X., Zhang, Y., Ganapathy, V., Gonzalez, F. J., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145409 · Cited by 221 · see citing works

The Early Settlers: Intestinal Microbiology in Early Life

Scholtens, P. A. M. J., Oozeer, R., Martı́n, R., Amor, K. B., & Knol, J. (2012) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-022811-101120 · Cited by 220 · see citing works

TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation.

Perino, A., Pols, T. W., Nomura, M., Stein, S., Pellicciari, R., & Schoonjans, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76289 · Cited by 209 · see citing works

Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells

Kumar, D. P., Rajagopal, S., Mahavadi, S., Mirshahi, F., Grider, J. R., Murthy, K. S., & Sanyal, A. J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.09.104 · Cited by 206 · see citing works

Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine

Gadaleta, R. M., Oldenburg, B., Willemsen, E. C. L., Spit, M., Murzilli, S., Salvatore, L., Klomp, L. W. J., Siersema, P. D., van Erpecum, K. J., & van Mil, S. W. C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.005 · Cited by 195 · see citing works

The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice

Péan, N., Doignon, I., Garcin, I., Besnard, A., Julien, B., Liu, B., Branchereau, S., Spraul, A., Guettier, C., Humbert, L., et al. (2013) · Hepatology · doi:10.1002/hep.26463 · Cited by 193 · see citing works

Bile acids, obesity, and the metabolic syndrome

Ma, H., & Patti, M. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.07.004 · Cited by 192 · see citing works

Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications

Jones, M. L., Tomaro-Duchesneau, C., Martoni, C. J., & Prakash, S. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.758706 · Cited by 190 · see citing works

Related actions of probiotics and antibiotics on gut microbiota and weight modification

Angelakis, E., Merhej, V., & Raoult, D. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70179-8 · Cited by 190 · see citing works

Suppression of LPS-Induced TNF-α Production in Macrophages by cAMP Is Mediated by PKA-AKAP95-p105

Wall, E. A., Zavzavadjian, J. R., Chang, M. S., Randhawa, B., Zhu, X., Hsueh, R. C., Liu, J., Driver, A., Bao, X. R., Sternweis, P. C., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000202 · Cited by 189 · see citing works

Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium

Kazumori, H. (2005) · Gut · doi:10.1136/gut.2005.066209 · Cited by 182 · see citing works

Genetics and Environmental Interactions Shape the Intestinal Microbiome to Promote Inflammatory Bowel Disease Versus Mucosal Homeostasis

Sartor, R. B. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.10.036 · Cited by 178 · see citing works

Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery

Flynn, C. R., Albaugh, V. L., Cai, S. B., Cheung‐Flynn, J., Williams, P. E., Brucker, R. M., Bordenstein, S. R., Guo, Y. P., Wasserman, D. H., & Abumrad, N. N. (2015) · Nature Communications · doi:10.1038/ncomms8715 · Cited by 177 · see citing works

Role of the intestinal microbiome in liver disease

Henao‐Mejia, J., Elinav, E., Thaiss, C. A., Licona-Limón, P., & Flavell, R. A. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.07.001 · Cited by 167 · see citing works

Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance

Ma, Y., Huang, Y., Yan, L., Gao, M., & Liu, D. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-0986-7 · Cited by 166 · see citing works

Bile Acid Receptor TGR5 Agonism Induces NO Production and Reduces Monocyte Adhesion in Vascular Endothelial Cells

Kida, T., Tsubosaka, Y., Hori, M., Ozaki, H., & Murata, T. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301565 · Cited by 166 · see citing works

Maternal regulation of fetal development and health in adult life

Godfrey, K. M. (1998) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(98)00060-8 · Cited by 159 · see citing works

Bile Acid Signaling in Liver Metabolism and Diseases

Li, T., & Chiang, J. Y. L. (2011) · Journal of Lipids · doi:10.1155/2012/754067 · Cited by 158 · see citing works

Bile salts act as effective protein-unfolding agents and instigators of disulfide stress in vivo

Cremers, C. M., Knoefler, D., Vitvitsky, V., Banerjee, R. V., & Jakob, U. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401941111 · Cited by 154 · see citing works

Bacterial Bile Metabolising Gene Abundance in Crohn's, Ulcerative Colitis and Type 2 Diabetes Metagenomes

Labbé, A., Ganopolsky, J. G., Martoni, C., Prakash, S., & Jones, M. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115175 · Cited by 144 · see citing works

The quantification of cholesterol excretion and degradation in the isotopic steady state in the rat: the influence of dietary cholesterol

Wilson, J. D. (1964) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40214-7 · Cited by 143 · see citing works

Mismatched pre- and postnatal nutrition leads to cardiovascular dysfunction and altered renal function in adulthood

Cleal, J. K., Poore, K. R., Boullin, J. P., Khan, O. A., Chau, R., Hambidge, O., Torrens, C., Newman, J. P., Poston, L., Noakes, D. E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610373104 · Cited by 137 · see citing works

The Role of Bile and Bile Acids in Bacterial Translocation in Obstructive Jaundice in Rats

Ding, J. W., Andersson, R., Soltesz, V., Willén, R., & Bengmark, S. (2008) · European Surgical Research · doi:10.1159/000129252 · Cited by 133 · see citing works

Absence of intestinal bile promotes bacterial translocation.

Slocum, M. M., Sittig, K. M., Specian, R. D., & Deitch, E. A. (1992) · PubMed · Cited by 132 · see citing works

Loss of FXR Protects against Diet-Induced Obesity and Accelerates Liver Carcinogenesis in ob/ob Mice

Zhang, Y., Ge, X., Heemstra, L. A., Chen, W., Xu, J., Smith, J. L., Ma, H., Kasim, N., Edwards, P. A., & Novak, C. M. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1157 · Cited by 127 · see citing works

Dual Activation of the Bile Acid Nuclear Receptor FXR and G-Protein-Coupled Receptor TGR5 Protects Mice against Atherosclerosis

Miyazaki‐Anzai, S., Masuda, M., Levi, M., Keenan, A. L., & Miyazaki, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108270 · Cited by 125 · see citing works

Development of the Digestive System—Experimental Challenges and Approaches of Infant Lipid Digestion

Abrahamse, E., Minekus, M., van Aken, G. A., van de Heijning, B., Knol, J., Bartke, N., Oozeer, R., van der Beek, E. M., & Ludwig, T. (2012) · Food Digestion · doi:10.1007/s13228-012-0025-x · Cited by 124 · see citing works

Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease

Nijmeijer, R. M., Gadaleta, R. M., van Mil, S. W. C., van Bodegraven, A. A., Crusius, J. B. A., Dijkstra, G., Hommes, D. W., de Jong, D. J., Stokkers, P. C. F., Verspaget, H. W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023745 · Cited by 119 · see citing works

Characterization of bacterial community shift in human Ulcerative Colitis patients revealed by Illumina based 16S rRNA gene amplicon sequencing

Walujkar, S. A., Dhotre, D., Marathe, N., Lawate, P., Bharadwaj, R., & Shouche, Y. (2014) · Gut Pathogens · doi:10.1186/1757-4749-6-22 · Cited by 110 · see citing works

Probiotics—Interactions with Bile Acids and Impact on Cholesterol Metabolism

Pavlović, N., Stankov, K., & Mikov, M. (2012) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-012-9904-4 · Cited by 110 · see citing works

Biotransformations on steroid nucleus of bile acids

Bortolini, O., Medici, A., & Poli, S. (1997) · Steroids · doi:10.1016/s0039-128x(97)00043-3 · Cited by 106 · see citing works

The Bile Acid Sensor FXR Is Required for Immune-Regulatory Activities of TLR-9 in Intestinal Inflammation

Renga, B., Mencarelli, A., Cipriani, S., D’Amore, C., Carino, A., Bruno, A. M., Francisci, D., Zampella, A., Distrutti, E., & Fiorucci, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054472 · Cited by 106 · see citing works

Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice

Stroeve, J. H. M., Brufau, G., Stellaard, F., Gonzalez, F. J., Staels, B., & Kuipers, F. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.107 · Cited by 103 · see citing works

Tissue-specific function of farnesoid X receptor in liver and intestine

Zhu, Y., Li, F., & Guo, G. L. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2010.12.018 · Cited by 101 · see citing works

The effects of commensal microbiota on immune cell subsets and inflammatory responses

Chinen, T., & Rudensky, A. Y. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01083.x · Cited by 96 · see citing works

FXR silencing in human colon cancer by DNA methylation and KRAS signaling

Bailey, A. M., Zhan, L., Maru, D. M., Shureiqi, I., Pickering, C. R., Kiriakova, G. M., Izzo, J. G., He, N., Wei, C., Baladandayuthapani, V., et al. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00234.2013 · Cited by 85 · see citing works

GPBAR1/TGR5 Mediates Bile Acid-Induced Cytokine Expression in Murine Kupffer Cells

Lou, G., Ma, X., Fu, X., Meng, Z., Zhang, W., Wang, Y., Ness, C. V., Yu, D. D., Xu, R., & Huang, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093567 · Cited by 81 · see citing works

The Immunomodulatory Role of Bile Acids

Sipka, S., & Bruckner, G. G. (2014) · International Archives of Allergy and Immunology · doi:10.1159/000366100 · Cited by 80 · see citing works

The infant intestinal microbiome: Friend or foe?

Mshvildadze, M., & Neu, J. (2010) · Early Human Development · doi:10.1016/j.earlhumdev.2010.01.018 · Cited by 78 · see citing works

The Impact of Farnesoid X Receptor Activation on Intestinal Permeability in Inflammatory Bowel Disease

Stojančević, M., Stankov, K., & Mikov, M. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/538452 · Cited by 77 · see citing works

Inhibition of Tumor Necrosis Factor-Alpha and lnterleukin-1-Beta Production by Beta-Adrenoceptor Agonists from Lipopolysaccharide- Stimulated Human Peripheral Blood Mononuclear Cells

Yoshimura, T., Kurita, C., Nagao, T., Usami, E., Nakao, T., Watanabe, S., Kobayashi, J., Yamazaki, F., Tanaka, H., Inagaki, N., et al. (2008) · Pharmacology · doi:10.1159/000139481 · Cited by 72 · see citing works

SUMOylation of the Farnesoid X Receptor (FXR) Regulates the Expression of FXR Target Genes*

Balasubramaniyan, N., Luo, Y., Sun, A.-Q., & Suchy, F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.443937 · Cited by 72 · see citing works

The association of bile acid excretion and atherosclerotic coronary artery disease

Charach, G., Grosskopf, I., Rabinovich, A., Shochat, M. K., Weintraub, M. S., & Rabinovich, P. (2010) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x10388682 · Cited by 69 · see citing works

Molecular-Phylogenetic Characterization of the Microbiota in Ulcerated and Non-Ulcerated Regions in the Patients with Crohn's Disease

Li, Q., Wang, C., Tang, C. X., Li, N., & Li, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034939 · Cited by 63 · see citing works

Characterization of chenodeoxycholic acid as an endogenous antagonist of the G-coupled formyl peptide receptors

Chen, X., Yang, D., Shen, W., Dong, H., Wang, J. M., Oppenheim, J. J., & Howard, O. M. Z. (2000) · Inflammation Research · doi:10.1007/s000110050656 · Cited by 60 · see citing works

Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel disease

Attinkara, R., Mwinyi, J., Truninger, K., Reguła, J., Gaj, P., Rogler, G., Kullak-Ublick, G. A., Eloranta, J. J., & The Swiss IBD Cohort Study Group (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-461 · Cited by 56 · see citing works

Microbiota prevents cholesterol loss from the body by regulating host gene expression in mice

Zhong, C., Sun, W., Ma, Y., Zhu, H., Yang, P., Wei, H., Zeng, B., Zhang, Q., Liu, Y., Li, W., et al. (2015) · Scientific Reports · doi:10.1038/srep10512 · Cited by 55 · see citing works

Catabolism and elimination of cholesterol in germfree rats

Wöstmann, B. S. J., Wiech, N. L., & Kung, E. (1966) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39588-2 · Cited by 49 · see citing works

Deoxycholic Acid Conjugates Are Muscarinic Cholinergic Receptor Antagonists

Raufman, J.-P., Chen, Y., Zimniak, P., & Cheng, K. (2002) · Pharmacology · doi:10.1159/000064347 · Cited by 47 · see citing works

Pharmacological Activation of the Bile Acid Nuclear Farnesoid X Receptor Is Feasible in Patients with Quiescent Crohn's Colitis

van Schaik, F. D. M., Gadaleta, R. M., Schaap, F. G., van Mil, S. W. C., Siersema, P. D., Oldenburg, B., & van Erpecum, K. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049706 · Cited by 25 · see citing works

Letter to the editor regarding the report of Dubocet al: connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel disease

Jones, M. L., Martoni, C., & Prakash, S. (2012) · Gut · doi:10.1136/gutjnl-2012-303867 · Cited by 22 · see citing works

Transcriptional Regulation of the Intestinal Nuclear Bile Acid Farnesoid X Receptor (FXR) by the caudal-related Homeobox 2 (CDX2)

Modica, S., Cariello, M., Morgano, A., Groß, I., Vegliante, M. C., Murzilli, S., Salvatore, L., Freund, J., Sabbà, C., & Moschetta, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.571513 · Cited by 18 · see citing works

The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies

Wiertsema, S. P., van Bergenhenegouwen, J., Garssen, J., & Knippels, L. M. J. (2021) · Nutrients · doi:10.3390/nu13030886 · Cited by 558 · see citing works

Profiling the human intestinal environment under physiological conditions

Shalon, D., Culver, R. N., Grembi, J. A., Folz, J., Treit, P. V., Shi, H., Rosenberger, F. A., Dethlefsen, L., Meng, X., Yaffe, E., et al. (2023) · Nature · doi:10.1038/s41586-023-05989-7 · Cited by 484 · see citing works

Gut Microbiota in Hypertension and Atherosclerosis: A Review

Verhaar, B. J. H., Prodan, A., Nieuwdorp, M., & Muller, M. (2020) · Nutrients · doi:10.3390/nu12102982 · Cited by 411 · see citing works

Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation?

Fukui, H. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000447252 · Cited by 358 · see citing works

Fucoidan Ameliorated Dextran Sulfate Sodium-Induced Ulcerative Colitis by Modulating Gut Microbiota and Bile Acid Metabolism

Liu, X., Zhang, Y., Li, W., Zhang, B., Yin, J., Liuqi, S., Wang, J., Peng, B., & Wang, S. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c06417 · Cited by 289 · see citing works

Guts and Gall: Bile Acids in Regulation of Intestinal Epithelial Function in Health and Disease

Hegyi, P., Maléth, J., Walters, J. R., Hofmann, A. F., & Keely, S. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00054.2017 · Cited by 269 · see citing works

Shaping the Gut Microbiota by Breastfeeding: The Gateway to Allergy Prevention?

van den Elsen, L. W. J., Garssen, J., Burcelin, R., & Verhasselt, V. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00047 · Cited by 270 · see citing works

Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism

Dong, S., Zhu, M., Wang, K., Zhao, X., Hu, L., Jing, W., Lu, H., & Wang, S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105767 · Cited by 209 · see citing works

Sex differences in lipid metabolism are affected by presence of the gut microbiota

Baars, A., Oosting, A., Lohuis, M. A. M., Koehorst, M., Aidy, S. E., Hugenholtz, F., Smidt, H., Mischke, M., Boekschoten, M. V., Verkade, H. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31695-w · Cited by 131 · see citing works

Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis

Han, B., Lv, X., Liu, G., Li, S., Fan, J., Chen, L., Huang, Z., Lin, G., Xu, X., Huang, Z., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2232143 · Cited by 116 · see citing works

The gut microbiome-bile acid axis in hepatocarcinogenesis

Wu, L., Feng, J., Li, J., Yu, Q., Ji, J., Wu, J., Dai, W., & Guo, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111036 · Cited by 103 · see citing works

Reprogramming of pro-inflammatory human macrophages to an anti-inflammatory phenotype by bile acids

Wammers, M., Schupp, A.-K., Bode, J., Ehlting, C., Wolf, S., Deenen, R., Köhrer, K., Häussinger, D., & Graf, D. (2018) · Scientific Reports · doi:10.1038/s41598-017-18305-x · Cited by 88 · see citing works

The functions of gut microbiota-mediated bile acid metabolism in intestinal immunity

He, Y., Shaoyong, W., Chen, Y., Li, M., Gan, Y., Sun, L., Liu, Y., Wang, Y., & Jin, M. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.015 · Cited by 95 · see citing works

Gut microbiota, fatty liver disease, and hepatocellular carcinoma

Chu, H., Williams, B., & Schnabl, B. (2018) · Liver Research · doi:10.1016/j.livres.2017.11.005 · Cited by 84 · see citing works

Synbiotic encapsulation of probiotic Latobacillus plantarum by alginate -arabinoxylan composite microspheres

Wu, Y., & Zhang, G. (2018) · LWT · doi:10.1016/j.lwt.2018.03.034 · Cited by 83 · see citing works

The influence of probiotics on bile acids in diseases and aging

Sivamaruthi, B. S., Fern, L. A., Rashidah Pg Hj Ismail, D. S. N., & Chaiyasut, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110310 · Cited by 73 · see citing works

Metagenomic analysis of bile salt biotransformation in the human gut microbiome

Das, P., Marcišauskas, S., Ji, B., & Nielsen, J. (2019) · BMC Genomics · doi:10.1186/s12864-019-5899-3 · Cited by 71 · see citing works

Gut Microbiota‐Bile Acid Crosstalk in Diarrhea‐Irritable Bowel Syndrome

Zhan, K., Zheng, H., Jian-qing, L., Wu, H., Qin, S., Luo, L., & Huang, S. (2020) · BioMed Research International · doi:10.1155/2020/3828249 · Cited by 70 · see citing works

Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases

Wang, Y., Xu, H., Zhou, X., Chen, W., & Zhou, H. (2024) · Medical Review · doi:10.1515/mr-2024-0020 · Cited by 61 · see citing works

Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis

Vincenzo, F. D., Puca, P., Lopetuso, L. R., Petito, V., Masi, L., Bartocci, B., Murgiano, M., Felice, M. D., Petronio, L., Gasbarrini, A., et al. (2022) · Nutrients · doi:10.3390/nu14132664 · Cited by 57 · see citing works

The role of bile acid receptor TGR5 in regulating inflammatory signalling

Ye, D., He, J., & He, X. (2024) · Scandinavian Journal of Immunology · doi:10.1111/sji.13361 · Cited by 57 · see citing works

Gut microbiota is a potential goalkeeper of dyslipidemia

Lei, L., Zhao, N., Zhang, L., Chen, J., Liu, X., & Piao, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.950826 · Cited by 58 · see citing works

Comparative effect of black, green, oolong, and white tea intake on weight gain and bile acid metabolism

Sun, L., Xu, H., Ye, J., & Gaikwad, N. W. (2019) · Nutrition · doi:10.1016/j.nut.2019.02.006 · Cited by 54 · see citing works

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer

Zhou, M.-J., Wang, D., Li, X., Cao, Y., Yi, C.-X., Ocansey, D. K. W., Zhou, Y., & Mao, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1016836 · Cited by 51 · see citing works

Bile acid metabolism in health and ageing-related diseases

Li, X., Fang, C., Zhao, R., Zou, L., Miao, H., & Zhao, Y. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116313 · Cited by 49 · see citing works

Schisandrin protects against ulcerative colitis by inhibiting the SGK1/NLRP3 signaling pathway and reshaping gut microbiota in mice

Wang, X., Shen, C., Wang, X., Tang, J., Wu, Z., Huang, Y., Shao, W., Geng, K., Xie, H., & Pu, Z. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00815-8 · Cited by 45 · see citing works

Farnesoid X Receptor Agonists: A Promising Therapeutic Strategy for Gastrointestinal Diseases

Almeqdadi, M., & Gordon, F. D. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.09.013 · Cited by 47 · see citing works

Role of metabolites derived from gut microbiota in inflammatory bowel disease

Zheng, L., Wen, X., & Duan, S.-L. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i9.2660 · Cited by 43 · see citing works

Discovery of Betulinic Acid Derivatives as Potent Intestinal Farnesoid X Receptor Antagonists to Ameliorate Nonalcoholic Steatohepatitis

Zhang, C., Liu, Y., Wang, Y., Ge, X., Jiao, T., Yin, J., Wang, K., Li, C., Guo, S., Xie, X., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01394 · Cited by 40 · see citing works

Short- and long-term effects of amoxicillin/clavulanic acid or doxycycline on the gastrointestinal microbiome of growing cats

Stavroulaki, E. M., Suchodolski, J. S., Pilla, R., Fosgate, G. T., Sung, C., Lidbury, J. A., Steiner, J. M., & Xenoulis, P. G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253031 · Cited by 38 · see citing works

Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes

Kriss, M. S., Verna, E. C., Rosen, H. R., & Lozupone, C. (2018) · Transplantation · doi:10.1097/tp.0000000000002568 · Cited by 37 · see citing works

Gut–Brain Axis and Bile Acid Signaling: Linking Microbial Metabolism to Brain Function and Metabolic Regulation

Stanimirov, B., Đanić, M., Pavlović, N., Zaklan, D., Lazarević, S., Mikov, M., & Stankov, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412167 · Cited by 37 · see citing works

Betaine supplementation mitigates intestinal damage and decreases serum bacterial endotoxin in cirrhotic rats

Ommati, M. M., Farshad, O., Mousavi, K., Jamshidzadeh, A., Azmoon, M., Heidari, S., Azarpira, N., Niknahad, H., & Heidari, R. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100179 · Cited by 31 · see citing works

<i>Lactiplantibacillus plantarum</i> strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans

Padro, T., Santisteban, V., Huedo, P., Puntes, M., Aguiló, M., Espadaler-Mazo, J., & Badimon, L. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae061 · Cited by 32 · see citing works

Bile acids induce IL-1α and drive NLRP3 inflammasome-independent production of IL-1β in murine dendritic cells

Oleszycka, E., O’Brien, E. C., Freeley, M., Lavelle, E. C., & Long, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1285357 · Cited by 29 · see citing works

7-Methylation of Chenodeoxycholic Acid Derivatives Yields a Substantial Increase in TGR5 Receptor Potency

Nakhi, A., McDermott, C. M., Stoltz, K. L., John, K., Hawkinson, J. E., Ambrose, E. A., Khoruts, A., Sadowsky, M. J., & Dosa, P. I. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00770 · Cited by 29 · see citing works

Nuclear receptors: a bridge linking the gut microbiome and the host

Wang, Z., Chen, W., & Wang, Y. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00407-y · Cited by 26 · see citing works

The Expression Levels of Genes Responsible for the Enzymatic Activity of Bile Salt Hydrolase (BSH) and the Relationship of Cholesterol Assimilation in L. plantarum and L. paracasei

Ertürkmen, P., Fırıncıoğulları, B., & Öner, Z. (2023) · Current Microbiology · doi:10.1007/s00284-023-03311-2 · Cited by 25 · see citing works

Lycium barbarum polysaccharide remodels colon inflammatory microenvironment and improves gut health

Li, R., Yang, P., Liu, B., Ye, Z., Zhang, P., Li, M.-J., Gong, Y.-J., Huang, Y., Yang, L., & Li, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30594 · Cited by 25 · see citing works

Bile acid–gut microbiota crosstalk in irritable bowel syndrome

Gu, Y., Li, L., Yang, M., Liu, T., Song, X., Qin, X., Xu, X. J., Liu, J., Wang, B., & Cao, H. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2058353 · Cited by 25 · see citing works

Gut microbiota: A potential therapeutic target for management of diabetic retinopathy?

Yempén, R. E. A., Venzel, R., Campos, M. C. P., de Oliveira, L. P., Lins, R. V. D., Pessoni, A. M., Fanaro, G. B., Souza, A. D. O., Calaza, K. D. C., Alves, J. L. D. B., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120060 · Cited by 22 · see citing works

Metabolite trajectories across the perinatal period and mental health: A preliminary study of tryptophan-related metabolites, bile acids and microbial composition

Kimmel, M., Jin, W., Xia, K., Lun, K., Azcárate-Peril, M. A., Plantinga, A., Wu, M. C., Kachouei, S. A., Rackers, H., Carroll, I. M., et al. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113635 · Cited by 22 · see citing works

Deciphering the role of gut metabolites in non-alcoholic fatty liver disease

Ralli, T., Saifi, Z., Tyagi, N., Vidyadhari, A., Aeri, V., & Kohli, K. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2142091 · Cited by 22 · see citing works

An intestinal-targeting near-infrared probe for imaging nitroreductase in inflammatory bowel disease

Li, T., Gu, Q.-S., Chao, J., Liu, T., Mao, G., Li, Y., & Li, C. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.135181 · Cited by 20 · see citing works

Structural characterization and therapeutic potential of exopolysaccharide EPS-W-1 from Lactiplantibacillus plantarum strain ZL1 isolated from kimchi against DSS-induced colitis

Li, Z., Saravanakumar, K., Park, S., Yao, L., Kim, Y. W., Jo, J., Choi, S. Y., Yoo, G., Lee, P. J., Kim, S., et al. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.123997 · Cited by 19 · see citing works

Immunocyte lipid metabolic reprogramming: a novel pathway for targeted intervention in autoimmune diseases

Cui, Y.-Y., Feng, Z.-D., Zhao, Q.-H., Dai, H., Zheng, Y., Rui, H.-L., & Liu, B.-L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1713148 · Cited by 17 · see citing works

A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis

Peters, D. E., Norris, L., Tenora, L., Šnajdr, I., Ponti, A. K., Zhu, X., Sakamoto, S., Veeravalli, V., Pradhan, M., Alt, J., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn7491 · Cited by 19 · see citing works

Ethanol extract of Pueraria lobata improve acute myocardial infarction in rats via regulating gut microbiota and bile acid metabolism

Zhang, P., Fang, Z., Zhao, M., Yi, B., Huang, Y., Yang, H., Guo, N., & Zhao, C. (2023) · Phytotherapy Research · doi:10.1002/ptr.8005 · Cited by 19 · see citing works

Gut microbiome in diabetic retinopathy: A systematic review and meta-analysis

Zhao, S., Qi, Y., Xu, W., & Zhang, J.-M. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106590 · Cited by 19 · see citing works

Myostatin Knockout Regulates Bile Acid Metabolism by Promoting Bile Acid Synthesis in Cattle

Wu, D., Gu, M., Wei, Z., Bai, C., Su, G., Liu, X., Zhao, Y., Yang, L., & Li, G. (2022) · Animals · doi:10.3390/ani12020205 · Cited by 19 · see citing works

Bridging two worlds: Host Microbiota crosstalk in health and dysregulation

Sanam, M., Hossain, C. F. T. Z., Hyder, T. B., Tarannum, R., Oishi, J. F., Rahman, K. A., Islam, S., Bulbul, N., Jime, J. S., Shishir, M. A., et al. (2025) · Innate Immunity · doi:10.1177/17534259251392993 · Cited by 20 · see citing works

The Impact of Fermented Milk Products on Gut Microbiota‐Derived Metabolites in Obesity: A Narrative Review

Mukarromah, T. A., Rustanti, N., Mahati, E., Suparmi, S., & Ayustaningwarno, F. (2025) · Journal of Food Science · doi:10.1111/1750-3841.70301 · Cited by 18 · see citing works

Armillaria luteo-virens Sacc Ameliorates Dextran Sulfate Sodium Induced Colitis through Modulation of Gut Microbiota and Microbiota-Related Bile Acids

Zhang, N.-N., Liu, J., Guo, X., Li, S., Wang, F., & Wang, M. (2021) · Nutrients · doi:10.3390/nu13113926 · Cited by 15 · see citing works

A triple-helix white tea polysaccharide alleviates ulcerative colitis via the gut microbiota-metabolites-inflammation regulatory axis.

Chen, X.-M., Dai, P.-F., Zhu, Y.-M., Jin, W.-W., Xie, Y., Yang, Z., Wang, Z.-Y., Jin, X., Lei, M.-J., Shi, L., et al. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.124716 · Cited by 16 · see citing works

Gut microbiota: A new therapeutic target for diabetic cardiomyopathy

Yuan, S., Cai, Z., Luan, X., Wang, H., Zhong, Y., Deng, L., & Feng, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.963672 · Cited by 15 · see citing works

Gut Microbiota as an Emerging Therapeutic Avenue for the Treatment of Nonalcoholic Fatty Liver Disease

Ralli, T., Neupane, Y. R., Saifi, Z., & Kohli, K. (2021) · Current Pharmaceutical Design · doi:10.2174/1389201022666210625141526 · Cited by 14 · see citing works

Marine-Algal-Derived Postbiotics Modulating the Gut Microbiota–Adipose Tissue Axis in Obesity: A New Frontier

Limijadi, E. K. S., Tjandra, K. C., Permatasari, H. K., Augusta, P. S., Surya, R., Harbuwono, D. S., & Nurkolis, F. (2025) · Nutrients · doi:10.3390/nu17233774 · Cited by 14 · see citing works

Investigating bile acid-mediated cholestatic drug-induced liver injury using a mechanistic model of multidrug resistance protein 3 (MDR3) inhibition

Beaudoin, J. J., Yang, K., Adiwidjaja, J., Taneja, G., Watkins, P. B., Siler, S. Q., Howell, B. A., & Woodhead, J. L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1085621 · Cited by 11 · see citing works

Proteome Profiling by Label‐Free Mass Spectrometry Reveals Differentiated Response of Campylobacter jejuni 81–176 to Sublethal Concentrations of Bile Acids

Masanta, W. O., Zautner, A. E., Lugert, R., Bohne, W., Groß, U., Leha, A., Dakna, M., & Lenz, C. (2018) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201800083 · Cited by 10 · see citing works

Interaction Between Human Microbiota, Immune System, and Hepatitis C Virus Infection: A Narrative Review

Frumento, D., & Ţălu, Ş. (2025) · Applied Sciences · doi:10.3390/app15063157 · Cited by 9 · see citing works

Gut microbiome in type 2 diabetes: insights from metagenomics, multi-omics, and diet–microbe interactions

Zhang, Y., & Wang, D. D. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2644682 · Cited by 9 · see citing works

Discovery and Optimization of Novel Nonbile Acid FXR Agonists as Preclinical Candidates for the Treatment of Inflammatory Bowel Disease

Li, Y., Xu, T., Zhao, Y., Zhang, H., Liu, Z., Wang, H., Huang, C.-Y., Shu, Z., Gao, L., Xie, R., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02304 · Cited by 9 · see citing works

Pathogenesis and intervention strategies for metabolic dysfunction–associated fatty liver disease from the perspective of the gut–microbiota–liver axis

Liao, J., Zhou, Z., Lv, Y., Zhang, Y., Liu, S., Tang, H., Qv, F., Wang, S., Yang, L., Lu, Y., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1667180 · Cited by 8 · see citing works

Gut Microbiota and Diabetes: Pioneering New Treatment Frontiers

Shakya, R., Sivakumar, P. M., & Prabhakar, P. K. (2025) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303342579241119155225 · Cited by 8 · see citing works

Profiling of the human intestinal microbiome and bile acids under physiologic conditions using an ingestible sampling devicePreprint

Shalon, D., Culver, R. N., Grembi, J. A., Folz, J. S., Treit, P. V., Dethlefsen, L., Meng, X., Yaffe, E., Spencer, S. P., Shi, H., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.19.476920 · Cited by 8 · see citing works

Fecal microbiota transplantation in pigs: current status and future perspective

Rahman, R., Marcolla, C. S., & Willing, B. P. (2025) · Animal Microbiome · doi:10.1186/s42523-025-00440-w · Cited by 9 · see citing works

The Placenta–Gut Microbiota Axis in Gestational Diabetes Mellitus: Molecular Mechanisms, Crosstalk, and Therapeutic Perspectives

Vass, R. A., Mikó, É., Prémusz, V., Vari, S. G., Kovacs, K., Bódis, J., & Ertl, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010312 · Cited by 7 · see citing works

The Role of Bile Acid in Immune‐Mediated Skin Diseases

Ma, H., Li, R., Qu, B., Liu, Y., Li, P., & Zhao, J. (2025) · Experimental Dermatology · doi:10.1111/exd.70108 · Cited by 6 · see citing works

Gut microbiota-metabolite interactions in drug-induced liver injury: mechanisms, biomarkers, and therapeutic perspectives

Mao, X., Hu, X., & Fang, J. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1737234 · Cited by 6 · see citing works

Crosstalks between NOD1 and Histone H2A Contribute to Host Defense against Streptococcus agalactiae Infection in Zebrafish

Wu, X., Xiong, F., Fang, H., Zhang, J., & Chang, M. (2021) · Antibiotics · doi:10.3390/antibiotics10070861 · Cited by 6 · see citing works

Compact Miniaturized Bioluminescence Sensor Based on Continuous Air-Segmented Flow for Real-Time Monitoring: Application to Bile Salt Hydrolase (BSH) Activity and ATP Detection in Biological Fluids

Roda, A., Greco, P., Simoni, P., Marassi, V., Moroni, G., Gioiello, A., & Roda, B. (2021) · Chemosensors · doi:10.3390/chemosensors9060122 · Cited by 6 · see citing works

Dietary berberine ameliorates glucose metabolism by regulating the FXR pathway in largemouth bass (Micropterus salmoides)

Yang, H.-C., Wang, G.-J., Xia, Y. L., Tian, J., Xie, J. H., Zhang, K., Li, Z., Yu, E., Li, H.-Y., Gong, W., et al. (2024) · Aquaculture Reports · doi:10.1016/j.aqrep.2024.101988 · Cited by 5 · see citing works

Postbiotics as Multifunctional Bioactives: Mechanistic Insights and Translational Applications in Host Physiology and Microbial Ecosystem Modulation

Sasidharan, N. B., Hely, S., John, S., Arun, K., Raveendran, N. J., Ghanta, R., Kumar, S. S., Nair, K. A., Pal, S., Sunilkumar, D., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14061230 · Cited by 5 · see citing works

Advancing our understanding of the influence of drug induced changes in the gut microbiome on bone health

Bailey, S., & Fraser, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1229796 · Cited by 6 · see citing works

Gut microbiota and glycochenodeoxycholic role in liver metastasis of breast cancer

Yan, L., Tan, Q., Zhu, J. X., He, Y., Tao, P., & He, J. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117128 · Cited by 5 · see citing works

Association of Probiotics and Prebiotics with Human Microbiome and the Functioning of Immune System

Dey, P., Mukherjee, S. K., & Parai, D. (2023) · Springer eBooks · doi:10.1007/978-981-99-1463-0_6 · Cited by 6 · see citing works

Taurocholate uptake by Caco-2 cells is inhibited by pro-inflammatory cytokines and butyrate

Couto, M., Andrade, N., Magro, F., & Martel, F. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156307 · Cited by 5 · see citing works

Microbiota-derived metabolites as nutritional signals in insulin resistance and obesity

Gupta, R., Saini, P., Srivastava, V., Ittishree, Manikandan, P., Singh, R., & Zargar, A. A. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.103279 · Cited by 4 · see citing works

Role of gut microbiota in the development of metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease

Sokal-Dembowska, A., Ergan, K., & Jarmakiewicz-Czaja, S. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i40.111375 · Cited by 4 · see citing works

Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder

Li, X., Wang, H., Li, Y., Huang, M., Li, X., Yu, Z., Li, P., & Liu, R. (2025) · Acta Materia Medica · doi:10.15212/amm-2024-0082 · Cited by 4 · see citing works

Clostridium butyricum RH2 ameliorates diarrhea in juvenile mice under continuous antibiotic exposure by modulating gut microbiota and metabolome

Zhao, Y., Gao, K., Shang, Y., Cheng, S., Ren, Q., Guo, F., & Wang, Y. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.01976-25 · Cited by 3 · see citing works

The Gut–Brain–Immune Axis: Multi-Omics Insights into Neurodegenerative and Metabolic Diseases

Khan, S.-U.-D., Chauhan, V., Chaudhary, A. A., & Khan, M. (2026) · Cells · doi:10.3390/cells15121089 · Cited by 3 · see citing works

Harnessing gut-derived bioactives and AI diagnostics for the next generation of type 2 diabetes solutions

Tseyslyer, Y. V., Malyi, V., Saifullina, M., Tsyryuk, O., Shvets, Y. V., Penchuk, Y., Kovalchuk, I., Kovalchuk, O. I., Korotkyi, O., Bulda, V., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1699954 · Cited by 2 · see citing works

Integrating bile acid metabolism into precision nutrition strategies for improved swine performance

Li, S.-Y., He, Y., Shaoyong, W., Wang, Y.-Z., & Jin, M.-L. (2025) · Animal Nutrition · doi:10.1016/j.aninu.2025.05.013 · Cited by 3 · see citing works

Harnessing gut microbiota for brain health: protective role of Hungatella hathewayi for post-mTBI cognitive impairment

Du, Q., Li, Q., Ullah, H., Wei, Y., Liao, G., Xiao, X., Yao, J., & Li, K. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-00922-y · Cited by 2 · see citing works

The role of the microbial-immune-bone axis in bone tumor development: mechanistic integration, systems modeling, and intervention prospects

Guo, Y., Wang, X., Wu, Y., Li, Y., & Wei, X. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1762046 · Cited by 2 · see citing works

Matrine improves bile acid metabolism and reduces inflammatory and oxidative stress in colitis via the JAK2 pathway

Jiang, Z.-X., Chen, X., Sun, Q., Yang, L.-C., Zhang, Y.-W., Wu, Q., Yao, H., Zhang, D., & Yuan, L. (2026) · Chinese Medicine · doi:10.1186/s13020-026-01387-z · Cited by 2 · see citing works

The Mediterranean Diet and Cardiovascular Protection: Biochemical Mechanisms with Emphasis on Platelet-Activating Factor

Detopoulou, P., Antonopoulou, S., Douvogianni, P., & Demopoulos, C. A. (2026) · Nutrients · doi:10.3390/nu18091320 · Cited by 2 · see citing works

Long-term effects of Nε-carboxymethyllysine intake on intestinal barrier permeability: Associations with gut microbiota and bile acids

Qiang, X., Wang, X., Liang, S., Li, S., Lv, Y., & Zhan, J. (2024) · Food Research International · doi:10.1016/j.foodres.2024.115543 · Cited by 3 · see citing works

Etiopathogenesis of NAFLD: Diet, Gut, and NASH

Miele, L., Biolato, M., Conte, C., Mangiola, F., Liguori, A., Gasbarrini, A., & Grieco, A. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_5 · Cited by 2 · see citing works

Bear Bile Powder Inhibits the Release of NLRP3 by Activating the cAMP/PKA/CREB Signaling Pathway to Treat Dextran Sulfate Sodium-induced Colitis in Mice

Tian, H., Cheng, L., Liang, Y., & Ren, Y. (2024) · Future Integrative Medicine · doi:10.14218/fim.2024.00009 · Cited by 1 · see citing works

Artemisia argyi extracts alleviated colitis in mice via modulating gut microbiota and bile acid metabolism

Chen, X., Liu, T., Han, J., Li, X., Wu, Y., Wang, L., Zhong, Y., Ji, Y., Zhou, K., Su, X., et al. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2025.9250558 · Cited by 1 · see citing works

Insights into the gut–liver–mitochondria axis in broilers: its role in metabolic health and nutritional regulation – A review

Yang, S., Song, Y., Sun, M., Su, Z., Qu, W., & Huo, M. (2026) · World s Poultry Science Journal · doi:10.1080/00439339.2026.2627512 · Cited by 1 · see citing works

TGR5 and FXR receptors in motor degeneration: Molecular mechanism, crosstalk pathways and therapeutic prospects

Banerjee, S., Panjwani, D., Singh, S., & Singh, T. G. (2026) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2026.578942 · Cited by 1 · see citing works

Guggulsterone as a modulator of the microbiota–bile acid–FXR axis: Molecular mechanisms and therapeutic potential in metabolic ageing

Ravikumar, A., & Sabarathinam, S. (2026) · Biochimie · doi:10.1016/j.biochi.2026.06.001 · Cited by 1 · see citing works

A Comprehensive Review on the Microbial Signatures and Metabolic Mechanisms Underlying the Gut-Alzheimer’s Disease Axis

Amruthavarshini, S. N., Kumari, N., & Anand, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06015-3 · Cited by 1 · see citing works

Gut microbiome drives glycodeoxycholic acid-mediated attenuation of hypertension

Aryal, S., Mell, B., Tummala, R., Manandhar, I., Kumariya, S., Kondapalli, N. B., Yeoh, B. S., Ahlidja, W., Akinola, O. M., Pachhain, S., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2691346 · Cited by 1 · see citing works

Loss of TGR5-activating bile acids is associated with disease activity in inflammatory bowel disease

Stallhofer, J., Leonhardt, J., Semmler, J., Neugebauer, S., Kiehntopf, M., Löhden, W., Homeister, L., Ungelenk, M., Hübner, C. A., Steube, A., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-63156-0 · Cited by 1 · see citing works

Microbial metabolites as emerging Biomodulators of host function and disease susceptibility

Hunzai, H., Ansari, A. A., Ghazanfar, S., Islam, A., Elkelish, A., Das, J., Chaudhary, P., Sridhar, S. B., Panigrahy, U. P., Mantry, S., et al. (2026) · PharmaNutrition · doi:10.1016/j.phanu.2026.100523 · Cited by 1 · see citing works

Pharmacomicrobiomics in metabolic syndrome and type 2 diabetes: the microbiome–drug–host triad

Strilić, D., Stanimirov, B., Pavlović, N., Lazarević, S., Mikov, M., Stanivukovic, T., & Đanić, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1831882 · Cited by 1 · see citing works

Bile acid modifications at the microbe-host interface: potential for nutraceutical and pharmaceutical interventions in host health

Joyce, S. A., & Gahan, C. G. M. (2016) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-041715-033159 · Cited by 241 · see citing works

Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders

Fiorucci, S., & Distrutti, E. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.09.001 · Cited by 539 · see citing works

Regulation of bile acid metabolism-related signaling pathways by gut microbiota in diseases

Jia, E., Liu, Z.-Y., Pan, M., Lu, J., & Ge, Q. (2019) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1900073 · Cited by 55 · see citing works

Gut Microbiota‐Bile Acid Crosstalk in Diarrhea‐Irritable Bowel Syndrome

Zhan, K., Zheng, H., Jian-qing, L., Wu, H., Qin, S., Luo, L., & Huang, S. (2020) · BioMed Research International · doi:10.1155/2020/3828249 · Cited by 70 · see citing works

Metabolic Effects of Bile Acids in the Gut in Health and Disease

Boesjes, M., & Brufau, G. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140303142053 · Cited by 38 · see citing works